Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Kidney Cancer Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
Oxford BioMedica
ArQule
Ono Pharmaceutical
Seattle Genetics
Amgen
Novartis
Taiwan Liposome
Immunicum
Exelixis
Abbott Laboratories
Genentech
AVEO Pharmaceuticals
Bristol-Myers Squibb
TRACON Pharmaceuticals
Wilex
Argos Therapeutics
Bayer
F Hoffmann-La Roche
Onyx Therapeutics
Prometheus Laboratories
Cerulean Pharma
Immatics biotechnologies
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Kidney Cancer Drug Market Overview 2018-2029
-
1.1 China Kidney Cancer Drug Industry Development Overview
-
1.2 China Kidney Cancer Drug Industry Development History
-
1.3 China Kidney Cancer Drug Industry Market Size (2018-2029)
-
1.4 China Kidney Cancer Drug Market Analysis by Type from Production Side
-
1.4.1 China Kidney Cancer Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Kidney Cancer Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Kidney Cancer Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Kidney Cancer Drug Market Analysis by Application from Consumption End
-
1.5.1 China Kidney Cancer Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Kidney Cancer Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Kidney Cancer Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Kidney Cancer Drug Market Analysis by Region
-
1.6.1 North China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Kidney Cancer Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Kidney Cancer Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Kidney Cancer Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Kidney Cancer Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Kidney Cancer Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Kidney Cancer Drug Industry Development
Chapter 3 Kidney Cancer DrugIndustry Chain Analysis
-
3.1 Kidney Cancer Drug Industry Chain
-
3.2 Kidney Cancer Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Kidney Cancer Drug Market
-
3.3 Kidney Cancer Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Kidney Cancer Drug Market
Chapter 4 China Kidney Cancer Drug Market, by Type
-
4.1 China Kidney Cancer Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Kidney Cancer Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Kidney Cancer Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Kidney Cancer Drug Production Volume and Growth Rate of Type 1
-
4.5.2 China Kidney Cancer Drug Production Volume and Growth Rate of Type 2
-
4.5.3 China Kidney Cancer Drug Production Volume and Growth Rate of Type 3
Chapter 5 China Kidney Cancer Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Kidney Cancer Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Kidney Cancer Drug Market Size and Growth Rate, by Application
-
5.5.1 China Kidney Cancer Drug Market Size and Growth Rate of Application 1
-
5.5.2 China Kidney Cancer Drug Market Size and Growth Rate of Application 2
-
5.5.3 China Kidney Cancer Drug Market Size and Growth Rate of Application 3
Chapter 6 China Kidney Cancer Drug Market, by Region
-
6.1 China Kidney Cancer Drug Production Volume and Production Value, by Region
-
6.2 China Kidney Cancer Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Kidney Cancer Drug Market Analysis
-
7.1 North China Kidney Cancer Drug Market, by Type
-
7.2 North China Kidney Cancer Drug Market, by Application
Chapter 8 Central China Kidney Cancer Drug Market Analysis
-
8.1 Central China Kidney Cancer Drug Market, by Type
-
8.2 Central China Kidney Cancer Drug Market, by Application
Chapter 9 South China Kidney Cancer Drug Market Analysis
-
9.1 South China Kidney Cancer Drug Market, by Type
-
9.2 South China Kidney Cancer Drug Market, by Application
Chapter 10 East China Kidney Cancer Drug Market Analysis
-
10.1 East China Kidney Cancer Drug Market, by Type
-
10.2 East China Kidney Cancer Drug Market, by Application
Chapter 11 Northeast China Kidney Cancer Drug Market Analysis
-
11.1 Northeast China Kidney Cancer Drug Market, by Type
-
11.2 Northeast China Kidney Cancer Drug Market, by Application
Chapter 12 Southwest China Kidney Cancer Drug Market Analysis
-
12.1 Southwest China Kidney Cancer Drug Market, by Type
-
12.2 Southwest China Kidney Cancer Drug Market, by Application
Chapter 13 Northwest China Kidney Cancer Drug Market Analysis
-
13.1 Northwest China Kidney Cancer Drug Market, by Type
-
13.2 Northwest China Kidney Cancer Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Kidney Cancer Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Oxford BioMedica
-
14.2.1 Oxford BioMedica Company Profile
-
14.2.2 Oxford BioMedica Kidney Cancer Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 ArQule
-
14.3.1 ArQule Company Profile
-
14.3.2 ArQule Kidney Cancer Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Ono Pharmaceutical
-
14.4.1 Ono Pharmaceutical Company Profile
-
14.4.2 Ono Pharmaceutical Kidney Cancer Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Seattle Genetics
-
14.5.1 Seattle Genetics Company Profile
-
14.5.2 Seattle Genetics Kidney Cancer Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Amgen
-
14.6.1 Amgen Company Profile
-
14.6.2 Amgen Kidney Cancer Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Novartis
-
14.7.1 Novartis Company Profile
-
14.7.2 Novartis Kidney Cancer Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Taiwan Liposome
-
14.8.1 Taiwan Liposome Company Profile
-
14.8.2 Taiwan Liposome Kidney Cancer Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Immunicum
-
14.9.1 Immunicum Company Profile
-
14.9.2 Immunicum Kidney Cancer Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Exelixis
-
14.10.1 Exelixis Company Profile
-
14.10.2 Exelixis Kidney Cancer Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Abbott Laboratories
-
14.11.1 Abbott Laboratories Company Profile
-
14.11.2 Abbott Laboratories Kidney Cancer Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Genentech
-
14.12.1 Genentech Company Profile
-
14.12.2 Genentech Kidney Cancer Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 AVEO Pharmaceuticals
-
14.13.1 AVEO Pharmaceuticals Company Profile
-
14.13.2 AVEO Pharmaceuticals Kidney Cancer Drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Bristol-Myers Squibb
-
14.14.1 Bristol-Myers Squibb Company Profile
-
14.14.2 Bristol-Myers Squibb Kidney Cancer Drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 TRACON Pharmaceuticals
-
14.15.1 TRACON Pharmaceuticals Company Profile
-
14.15.2 TRACON Pharmaceuticals Kidney Cancer Drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Wilex
-
14.16.1 Wilex Company Profile
-
14.16.2 Wilex Kidney Cancer Drug Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Argos Therapeutics
-
14.17.1 Argos Therapeutics Company Profile
-
14.17.2 Argos Therapeutics Kidney Cancer Drug Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Bayer
-
14.18.1 Bayer Company Profile
-
14.18.2 Bayer Kidney Cancer Drug Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 F Hoffmann-La Roche
-
14.19.1 F Hoffmann-La Roche Company Profile
-
14.19.2 F Hoffmann-La Roche Kidney Cancer Drug Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Onyx Therapeutics
-
14.20.1 Onyx Therapeutics Company Profile
-
14.20.2 Onyx Therapeutics Kidney Cancer Drug Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Prometheus Laboratories
-
14.21.1 Prometheus Laboratories Company Profile
-
14.21.2 Prometheus Laboratories Kidney Cancer Drug Market Performance
-
14.21.3 Product&Service Introduction
-
14.22 Cerulean Pharma
-
14.22.1 Cerulean Pharma Company Profile
-
14.22.2 Cerulean Pharma Kidney Cancer Drug Market Performance
-
14.22.3 Product&Service Introduction
-
14.23 Immatics biotechnologies
-
14.23.1 Immatics biotechnologies Company Profile
-
14.23.2 Immatics biotechnologies Kidney Cancer Drug Market Performance
-
14.23.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Kidney Cancer Drug Industry Research Conclusions
-
15.2 Kidney Cancer Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Kidney Cancer Drug Industry Market Size (2018-2029)
-
Figure China Kidney Cancer Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Kidney Cancer Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Kidney Cancer Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Kidney Cancer Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Kidney Cancer Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Kidney Cancer Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Kidney Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Kidney Cancer Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Kidney Cancer Drug Market Share by Type in 2018
-
Figure China Kidney Cancer Drug Market Share by Type in 2023
-
Figure China Kidney Cancer Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Kidney Cancer Drug Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Kidney Cancer Drug Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Kidney Cancer Drug Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Kidney Cancer Drug Market Share by Application in 2018
-
Figure China Kidney Cancer Drug Market Share by Application in 2023
-
Figure China Kidney Cancer Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Kidney Cancer Drug Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Kidney Cancer Drug Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Kidney Cancer Drug Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Kidney Cancer Drug Production Volume by Region (2018-2023)
-
Table China Kidney Cancer Drug Production Volume Share by Region (2018-2023)
-
Figure China Kidney Cancer Drug Production Volume Share by Region (2018-2023)
-
Table China Kidney Cancer Drug Production Value by Region (2018-2023)
-
Table China Kidney Cancer Drug Production Value Share by Region (2018-2023)
-
Figure China Kidney Cancer Drug Production Value Share by Region (2018-2023)
-
Table China Kidney Cancer Drug Sales Volume by Region (2018-2023)
-
Table China Kidney Cancer Drug Sales Volume Share by Region (2018-2023)
-
Figure China Kidney Cancer Drug Sales Volume Share by Region (2018-2023)
-
Table China Kidney Cancer Drug Sales Value by Region (2018-2023)
-
Table China Kidney Cancer Drug Sales Value Share by Region (2018-2023)
-
Figure China Kidney Cancer Drug Sales Value Share by Region (2018-2023)
-
Table North China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table North China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure North China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table North China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table North China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table Central China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Central China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table Central China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table South China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table South China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure South China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table South China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table South China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table East China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table East China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure East China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table East China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table East China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table Northeast China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table Southwest China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Kidney Cancer Drug Production Volume by Type (2018-2023)
-
Table Northwest China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Kidney Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Kidney Cancer Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Kidney Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Oxford BioMedica Company Profile
-
Table Oxford BioMedica Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table ArQule Company Profile
-
Table ArQule Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Ono Pharmaceutical Company Profile
-
Table Ono Pharmaceutical Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Seattle Genetics Company Profile
-
Table Seattle Genetics Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Taiwan Liposome Company Profile
-
Table Taiwan Liposome Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Immunicum Company Profile
-
Table Immunicum Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Exelixis Company Profile
-
Table Exelixis Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Abbott Laboratories Company Profile
-
Table Abbott Laboratories Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Genentech Company Profile
-
Table Genentech Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table AVEO Pharmaceuticals Company Profile
-
Table AVEO Pharmaceuticals Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table TRACON Pharmaceuticals Company Profile
-
Table TRACON Pharmaceuticals Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Wilex Company Profile
-
Table Wilex Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Argos Therapeutics Company Profile
-
Table Argos Therapeutics Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Company Profile
-
Table F Hoffmann-La Roche Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Onyx Therapeutics Company Profile
-
Table Onyx Therapeutics Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Prometheus Laboratories Company Profile
-
Table Prometheus Laboratories Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Cerulean Pharma Company Profile
-
Table Cerulean Pharma Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Immatics biotechnologies Company Profile
-
Table Immatics biotechnologies Kidney Cancer Drug Revenue, Price and Gross (2018-2023)
-
